Exchange: CSE·Updated 03:08 PM EDT

MYCO.CSE Mydecine Innovations Group Inc - Ordinary Shares New

$0.07
$0.005
(6.67%)
Today
Mkt Cap$4.39M
Vol121,045.00

About MYCO.CSE

Noveris Health Sciences, Inc. is a biotechnology company, which engages in the development of medications and therapies to address mental health disorders such as nicotine addiction and post-traumatic stress disorder (PTSD). The company was founded by Parente Carman, Damon Michaels, and Robert Roscow on September 27, 2013 and is headquartered in Vancouver, Canada.
50

Neutral Sentiment

How do you feel about MYCO.CSE?

Advertisement|Remove ads.